Acyline
GnRH II Receptor Antagonists
- User: Male
- Hormonal: Hormonal
-
Delivery type:
- Undetermined
-
Intended Duration:
- Undetermined
- Development Stage: Phase I
- Developer(s)/researcher(s): University of Washington, Monash University, Charles R. Drew University
Details
- API: Acyline
- Target: GnRH
- Inactive Materials: Undetermined
- Regimen: Undetermined
- MPT: Not Potential MPT
Product Status
No evidence of investigation after 2005
History
FI dose range finding studies completed in 2002, with additional development in 2004 and 2005. No additional evidence of development.